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Abstract
Background: The possibilities in the molecular genetics of long QT syndrome (LQTS) and hypertrophic
cardiomyopathy (HCM) has made family screening, with diagnostic and predictive genetic testing part of the
health care offer in genetic counselling of inherited arrhythmias, potentially affecting the subjective health among
these individuals. The study compared health status among patients at risk of arrhythmia because of family history
or clinical diagnosis of LQTS and HCM with reference health status scores of the general population.
Methods: In the period 2005-2007, 127 patients (mean age 45 years, 53.5% women), with a family history of
arrhythmia (n = 95) or a clinical diagnosis of LQTS (n = 12) or HCM (n = 19) referred for genetic counselling at the
medical genetic departments in Norway filled in a questionnaire (Short Form Health Survey SF-36) measuring
health status on eight domains. The patient SF-36 scores were compared to expected scores of the general
population by t-test, and the relationship between the socio-demographic variables, clinical status, and SF-36
domains were analysed by multiple linear regression.
Results: The total sample reported significant lower SF-36 score as compared to the general population scores for
the domain of general health (mean difference -7.3 (<0.001). When analysing the sample in subgroups according
to clinical status, the general health was still significant lower for the group of family risk and in the group of HCM.
In addition the physical functioning, role physical, vitality and role emotional domains were reduced for the latter
group. In general, employment, higher education and being referred to genetic counselling through a family
member were associated with better scores on the health status domains.
Conclusions: Having a genetic risk of arrhythmia affects general health significantly. In addition, patients with a
clinical diagnosis of HCM demonstrate a significantly poorer health in both physical and mental domains.
Background
Patients with long QT syndrome (LQTS) and hyper-
trophic cardiomyopathy (HCM) have a genetically based
increased risk for serious arrhythmias. Both patients and
family members therefore live with the threat of a pre-
mature sudden death. This threat applies especially to
children and teenagers, but can also affect adults [1,2].
The advances in gene technology have made it possible
to offer genetic testing, and at risk individuals and their
close relatives have the opportunity to receive genetic
counselling.
The penetrance (likelihood for actually developing the
disease) is varying, which leads to uncertainty of ever
experiencing clinical symptoms of the disease. The man-
ifestations of symptoms can range from asymptomatic
to sudden death, but there can be a lot of variation
between individuals and families. The two diseases are
structurally and functionally different from each other.
LQTS is an ion channel disease leading to a prolonged
QT interval with an increased propensity to ventricular
tachycardia manifesting as torsade de pointes [3]. HCM
is defined by the presence of increased ventricular wall
thickness or mass, having ruled out hypertension and
valve disease [4]. However, being genetic disorders caus-
ing arrhythmias they still have a lot in common in the
genetic counselling setting, where topics like inheritance
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patterns, symptoms, management and prevention are
being addressed according to guidelines [5].
Events and issues such as experiencing syncope, sur-
viving life-threatening arrhythmias and living with an
implantable cardioverter-defibrillator (ICD), have pre-
viously been shown to have an effect on health status
[6-8]. It is also well documented that uncertainty about
one’s health can be very distressing [9,10], as well as the
uncertainty regarding your children’s health [11,12].
Living with the genetic risk of arrhythmia and possible
sudden death may therefore affect health status of the
patient group referred to genetic counselling. However,
the knowledge of the health status of the patients com-
ing to genetic counselling because of a risk of inherited
arrhythmias is limited. Previous studies have mainly
focused on children at genetic risk and their parents’
higher distress levels as a reaction to that [13-15].
In the adult patient population a qualitative study of
living with LQTS reported that these patients reported
worries and limitations in daily life, but also here their
main concern was for their children or grandchildren
[16].
In adult HCM patients, living with HCM has been
reported to be associated with decreased levels of self
reported health status compared to the general popula-
tion [17], and one study also reported problems for the
patients to adjust to the diagnosis [18].
In Health research, the traditional outcomes mortality
and morbidity have been supplemented with subjective
accounts of health in patient groups of various diseases
[19]. In general, health status is measured by instru-
ments based on a multidimensional model of health,
such as the Short Form Health Survey [SF-36] which is
used in the present study. In SF-36, eight domains are
constructed from the Medical Outcomes Study (MOS)
(Boston, USA) which is relevant to functional status and
well-being, and that can directly be affected by disease
and treatment [20].
The patients coming to genetic counselling consist of
high risk individuals with the potential to develop an
arrhythmia. The arrhythmia risk may be present either
because of a family history of arrhythmia or that indivi-
duals have a clinical diagnosis such as long QT syn-
drome. Similarly the HCM group consists of persons
with a possible inherited risk not yet diagnosed and
patients with the clinical condition.
Because there is limited systematic information about
how the increased genetic risk affects the health status
of the heart patients with LQTS or HCM, as well as
their family members, we investigated the health status
in a Norwegian sample of patients at risk of inherited
arrhythmia prior to the genetic counselling session. Spe-
cifically, our research questions were; (1) Is there a rela-
tionship between living with genetic risk of inherited
arrhythmia and health status vulnerability? (2) What is
the relationship between socio-demographic variables,
clinical status and health status domains among the
patients at risk of arrhythmia coming to genetic
counselling?
Methods
Participants
The participants comprised of (a) Norwegian patients
with an increased risk of inherited arrhythmia, either
LQTS or HCM, not previously genetic tested and who
were consecutively referred or self-referred to genetic
counselling between the years 2005-2007 in Bergen,
Trondheim or Oslo and (b) control subjects based on
calculations from the normative data from the general
Norwegian population [21].
a) The arrhythmia risk patients
One hundred and seventy-three patients were asked
to participate in the study. Of these 39 (22.5%) did
not consent to participate and 7 (5.2%) did not
return the questionnaire, leaving 127 (73.4%)
patients included in the study.
b) The general population
SF-36 expected scores were calculated based on the
normative data from the general Norwegian popula-
tion aged 19-80 that were randomly drawn from the
Norwegian Population Register (n = 3500). In total
2323 (67%) responded [21].
Procedure
Participants filled in a questionnaire measuring health
status and socio-demographic variables, whereas their
clinical status was obtained from the medical records.
Information about the study and a consent form was
mailed to the patient together with the questionnaire 2-
4 weeks before the genetic counselling. The participants
received one reminder. The study was approved by the
Regional committee for medical research ethics in Wes-
tern Norway in September 2004.
Questionnaire
Short Form-36 Health Survey (SF-36) is a self-report
questionnaire that measures health status domains (0 =
worst health state. 100 = best health state) on eight sub-
scales; where physical functioning (PF), role limitation-
physical (RP), bodily pain (BP) and general health (GH)
are mainly considered physical health domains and vital-
ity (VT), social functioning (SF), role limitation-emo-
tional (RE) and mental health (MH) are considered
mental health domains. The general health and vitality
domains have both physical and mental aspects in their
construct. An additional point reports changes in health
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over the last year. The questionnaire is generic and mul-
tidimensional and it is suitable for administration to
large populations and to subgroups such as patients. Its
purpose is to be a measure of health status or health
outcome in cross-sectional and longitudinal studies. The
SF-36 has been shown to be a reliable and valid measure
across studies all over the world and the Norwegian ver-
sion exhibits satisfactory psychometric properties
[21-24].
Socio-demographic variables and clinical status
The socio-demographic variables age, sex, and marital
status, children, employment and education status,
heart-disease in the family, family history of sudden
death and/or genetic testing, and referral by physician/
self referral through family member were obtained from
the self-report questionnaire. The clinical status was col-
lected from the patients’ medical record and defined as
having a family risk of arrhythmia or having a clinical
diagnosis of either LQTS or HCM.
Statistical analysis
Descriptive analyses were performed for socio-demo-
graphic variables, clinical status and the health status
domains of SF-36. Descriptive statistics for SF-36 are
given as mean, standard deviation (SD) and number of
participants. SF-36 expected scores were calculated
based on the normative data from the general Norwe-
gian population aged 19-80 years that were randomly
drawn from the Norwegian Population Register (n =
3500) [21]. SF-36 expected scores for each of the
respondents were calculated for all health status
domains, controlling for age and sex. Bivariate analyses
were performed using paired samples t-tests [25] when
comparing health status in the different groups with
expected scores. Non-parametric tests were considered
for analyzing the two smaller subgroups, but gave the
same results with regard to statistical significance as the
parametric tests. It was therefore decided to present the
results with the parametric analysis, reporting mean dif-
ferences and p-values.
When measuring the impact of clinical status on levels
of health status, one-way analysis of variance (anova)
with post hoc comparisons, using the Tukey method to
correct for multiple testing was used.
Multiple linear regression analyses were performed on
the total arrhythmia-risk group to assess the impact of
the socio-demographic variables and clinical status on
the different health domains of SF-36. Models were
reported as unstandardised regression coefficients (b)
with standard error, p-values and determination coeffi-
cients (R2), adjusted. From a fully adjusted model with
all socio-demographic variables and clinical status
entered, a backward stepwise elimination of predictors
were performed to achieve a final model with variables
fulfilling the inclusion criteria with p ≤ 0.05 and
excluded with p ≥ 0.1 All other tests were two-tailed at
the 5% significance level. Data were analyzed using SPSS
version 15.0.
Results
The socio-demographic and clinical status of the
arrhythmia risk group is presented in table 1. The distri-
butions of SF-36 health status scores for the total
arrhythmia risk group are presented in figure 1, indicat-
ing some deviation from normal distribution.
Comparisons with the expected scores of the general
population
In table 2 the SF-36 health status scores among patients
at risk of inherited arrhythmias compared to the
expected scores of the general population is presented.
After adjusting for age and sex the total arrhythmia risk
group reported significant lower SF-36 health status
score as compared to the general population scores for
the domain of general health. When comparing the sub-
groups with the expected scores, the general health was
still significant lower for the group of family risk and in
the group of HCM. In addition the physical functioning,
role physical, vitality and role emotional domains were
reduced for the latter group. There were no significant
differences between the patients with a clinical diagnose
of LQTS and the expected scores, and the family risk
group had better scores on the domains of physical
health and bodily pain, than the general population.
Comparisons between the groups according to
clinical status
Table 3 report the impact of clinical status on levels of
health status, as measured with the eight SF-36 health
status domains. Patients with a clinical diagnosis of
HCM had significantly lower scores than the patients
with a clinical diagnosis of LQTS and the family risk
group on all physical health status domains, with the
exception of the domain of bodily pain where the mean
difference between having a diagnosis of LQTS or HCM
was non-significant. The most striking result was the
difference on the role physical domain (50 vs. 83.3 and
83.2). There were no statistically significant differences
in mental health status domains for the three groups.
The relationship between socio-demographic variables
and health status domains
In table 4 multiple regression analyses showed that
socio-demographic variables and clinical status could
explain considerable variability in the different health
status domains, ranging from 30.2% to 51.8%. Of the
physical health domains it was physical functioning that
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was best explained by the socio-demographic variables
(51.8%), while of the mental domains it was social func-
tioning (37.9%). Sex, age, employment and educational
status, family history of heart disease or sudden death,
referral by physician vs. family member, and clinical sta-
tus showed significant relationships with different health
status domains. Women scored lower than men on all
scales for bodily pain, vitality, and mental health
domains. Increasing age had a significant relationship to
reduced physical function and role-physical. Being
employed was related significantly to an increase of all
health domains, except for the mental health domain,
that was non-significant. Higher education status was
significantly associated to less bodily pain, better general
health, more vitality, higher degrees of social functioning
and better mental health. A family history of HCM had
a significant negative relationship with physical and gen-
eral health. Referral to genetic counselling by a physi-
cian had a significant negative relationship to all the
health domains. The clinical status of having the diagno-
sis of LQTS had a significant positive relationship with
the mental health domain.
Discussion
The present study demonstrates reduced health status in
the SF-36 domain of general health in the arrhythmia-
risk patients. The general health domain was reported
significantly lower than the general population with the
largest mean difference. In general, employment, higher
education and being referred to genetic counselling
through a family member were associated with better
scores on the health status domains.
The general health domain deals with a personal eva-
luation of both physical and mental health, including
current health, health outlook, and resistance to illness.
In the present study, the general health domain was
reduced among patients at genetic risk of arrhythmia,
even if the other physical health domains were indiffer-
ent or even better than the expected scores from the
general population. The mental health domains were
less than the reference scores, but none of them reached
statistical significance. Even if the finding may seem
inconsistent, considering what these patients are up
against, it might not be surprising. Living with and hav-
ing knowledge about genetic risk of sudden death in the
family can initiate genetic testing and health preventive
behaviours, but one can also imagine that it will have an
effect on how you perceive your health and health
outlook.
According to a psychological framework for analysing
risk of disease, the risk can be defined in terms of prob-
ability and effect [26]. The probability part of the risk
concept is the likelihood of some specific negative event
will occur as a result of the possible genetic
Table 1 Socio-demographic variables and clinical status
of the 127 arrhythmia risk patients coming to genetic
counselling
Variable Total
n = 127
%
100
Sex
Female 68 53.5
Male 59 46.5
Age Groups
29 or less: 26 20.5
30-39: 20 15.7
40-49: 31 24.4
50-59: 27 21.3
60-69: 11 8.7
70 or more: 12 9.4
Marital Status
Married/cohabitant 98 77.2
Single 17 13.4
Divorced/separated 7 5.5
Widow/widower 4 3.1
Missing 1 0.8
Children
Have children 99 78.0
Missing 2 1.6
Employment 86 67.7
Missing 1 0.8
Education Status
Primary school 26 20.5
High school 64 50.4
College/university 37 29.1
Missing
Heart-disease in family
Long QT syndrome (LQTS) 88 69.3
Hypertrophic cardiomyopathy (HCM) 39 30.7
Sudden Death Occurred in Family
Sudden Death 57 44.9
Missing 25 19.7
Genetic Testing Conducted in
Family
Genetic Testing 77 60.6
Missing 14 11.0
Referral
By physician 35 27.6
Self referred through family 90 70.9
Missing 2 1.6
Clinical Status
Family risk 95 74.8
Clinical diagnosis of LQTS 12 9.4
Clinical diagnosis of HCM 20 15.7
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Figure 1 Distribution of the SF-36 Health status scores.
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vulnerability. For most patients in our study there is a
high probability for heart disease, since the genetic vul-
nerability for heart disease is already known among first
degree family members. The probability for having
inherited mutation associated with heart disease is 50%
(autosomal dominant inheritance), although, the pene-
trance for actually developing the disease as well as the
intra-familial expression of the disease are varying. The
effect side of the risk concept is the severity or conse-
quence of the event. In a proportion of cases the event
is very serious and even fatal in this patient population.
With this in mind it can be the patients’ relation to liv-
ing with this risk that explain why they rate their gen-
eral health poorly. It has been shown that uncertainty
about survival can decrease the perception of general
health [8,9], and Loge et al discusses their similar
finding among Hodgkin’s disease survivors, that it may
reflect having lived with a potentially fatal disease [27].
Our participants are currently living with the risk of a
potentially fatal disease, but this does not seem to influ-
ence the other health domains.
In other patient groups coming to genetic counselling,
there have also been similar findings. In a study of
women with high risk for breast cancer due to family
history, subjects reported significant lower levels of
health status for domains related to mental health and
for general health compared to normative data, but
similar levels on domains related to physical health [28].
There were also differences in health status between
the subgroups and the expected scores of the general
population, and differences between the groups accord-
ing to clinical status. Patients with HCM had
Table 2 SF-36 Health status scores among patients at risk of inherited arrhythmias compared to the expected scores
of the general population*
SF-36 Health status domains Clinical status n Mean (SD) Mean diff. p-value
Physical functioning Total sample 122 88.2(16.4) 1.1 0.389
Family risk 91 90.6(14.2) 3.7 <0.001
LQTS 12 93.3(14.2) 1.7 0.678
HCM 19 73.2(19.5) -11.7 0.021
Role physical Total sample 126 78.2(35.5) 0.3 0.915
Family risk 95 83.2(31.5) 5.1 0.095
LQTS 12 83.3(34.3) -0.6 0.956
HCM 19 50.0(43.3) -23.3 0.024
Bodily pain Total sample 127 78.3(25.9) 3.4 0.138
Family risk 95 82.2(23.0) 7.1 0.003
LQTS 12 75.2(30.2) -2.9 0.735
HCM 20 62.0(30.8) -10.9 0.127
General health Total sample 126 69.5(20.5) -7.3 <0.001
Family risk 94 72.6(18.1) -4.6 0.012
LQTS 12 71.3(22.8) -8.5 0.224
HCM 20 54.1(23.9) -19.1 0.004
Vitality Total sample 127 55.7(24.8) -4.3 0.530
Family risk 95 58.3(24.7) -1.3 0.602
LQTS 12 53.9(29.5) -6.2 0.488
HCM 20 44.5(19.5) -17.4 0.001
Social functioning Total sample 127 83.4(22.9) -2.3 0.245
Family risk 95 85.4(20.4) -0.0 0.986
LQTS 12 83.3(29.4) -3.4 0.693
HCM 20 61.4(43.4) -12.7 0.068
Role emotional Total sample 124 77.8(36.9) -4.0 0.217
Family risk 93 80.5(34.6) -1.2 0.734
LQTS 12 83.3(38.9) -0.3 0.976
HCM 19 61.4(43.4) -20.1 0.054
Mental health Total sample 127 76.3(19.5) -2.5 0.155
Family risk 95 75.9(19.8) -2.6 0.197
LQTS 12 79.1(25.3) 0.8 0.912
HCM 20 76.3(14.0) -3.6 0.245
* Paired samples t-tests between the total sample, groups and expected scores of the general population reporting number of participants, means, standard
deviations, mean differences and p-values.
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significantly reduced scores on physical health status
domains compared to both the expected scores of the
general population, the patients with LQTS and the
family risk group, and reduced scores of the domains of
vitality and role emotional compared to the general
population. This is comparable with results from a study
of health related quality of life and psychological well-
being in patients with HCM, where the analysis of the
SF-36 indicated limitations in both the physical and
mental health domains [17]. In our study the LQTS
group also demonstrated lower scores on most of the
health domains but none were significant. This can be
due to the nature of the diseases, where HCM will have
more manifestations of physical symptoms that are
more prone to affect especially physical health domains,
whereas having a clinical diagnosis of LQTS or family
risk may cause more worries and distress because there
might be more uncertainties around symptoms, diagno-
sis and management of the disease, potentially affecting
more psychological measures as previous research have
shown [13,15,29-31].
In the present study, women scored significantly lower
than men on the domains of bodily pain, vitality and
mental health, domains that primarily measure well-
being, whereas not for the domains that measures
disability, such as physical functioning, role-physical,
social functioning and role-emotional. One explanation
of this might be that it is different for men and women
to live with the risk of uncertainty. It has been pre-
viously shown that impact of uncertainty associated with
children’s chronic health condition can have a relation-
ship with mothers mental and physical health, while
uncertainty does not affect fathers’ health in the same
way[12]. In the normative data of the general Norwegian
population all of the physical health status domains had
a strong relationship with age, and in three out of four
physical health domains women scored lower than men
[21].
Being employed had a positive relationship to both
physical and mental health domains in our study, which
is in line with epidemiological research conducted in
Norway that found better perceived health status in
employed, as compared to unemployed and disability
benefit recipients [32]. Lower education status predicted
also lower health status as reported from the normative
data of the Norwegian general population [21].
In a study of the psychological impact of risk for long
QT syndrome, parents of carrier children reported high
levels of distress. The distress was predicted by lower
education status along with previous history of distress
Table 3 Differences between groups according to clinical status*
SF-36 Health status domains Clinical status F-test statistic (p-value) Mean diff. p-value
Physical functioning Family risk-LQTS F2,121 = 11.3 -2.7 0.831
LQTS-HCM (<0.001) 20.2 0.001
Family risk-HCM 17.5 <0.001
Role physical Family risk-LQTS F2,125 = 7.8 -0.1 1.000
LQTS-HCM (0.001) 33.3 0.023
Family risk-HCM 33.2 <0.001
Bodily pain Family risk-LQTS F2,126 = 5,5 7.0 0.632
LQTS-HCM (0.005) 13.2 0.324
Family risk-HCM 20.2 0.004
General health Family risk-LQTS F2,126 = 7.5 1.3 0.975
LQTS-HCM (0.001) 17.3 0.044
Family risk-HCM 18.6 0.001
Vitality Family risk-LQTS F2,125 = 2.7 4.4 0.824
LQTS-HCM (0.073) 9.4 0.547
Family risk-HCM 13.8 0.060
Social functioning Family risk-LQTS F2,126 = 2.2 2.1 0.953
LQTS-HCM (0.117) 9.6 0.481
Family risk-HCM 11.6 0.096
Role emotional Family risk-LQTS F2,125 = 2.3 -2.9 0.964
LQTS-HCM (0.104) 21.9 0.237
Family risk-HCM 19.1 0.099
Mental health Family risk-LQTS F2,126 = 0.1 -3.1 0.860
LQTS-HCM (0.872) 2.8 0.920
Family risk-HCM -0.4 0.997
*ANOVA with Tukey correction for multiple post hoc tests for the health status domains.
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in person, knowledge of the disease for a longer time
period, sudden death in the family, and unsatisfied with
the disease-information [15]. In the present study
reduced scores on the mental health domain is best pre-
dicted by being female, having children, lower education
status and referral by physician, while experience of sud-
den death in the family did not have a significant rela-
tionship to mental health.
Implications for genetic counselling practice
The main aim of the genetic counselling is to help peo-
ple to understand and adapt to the medical, psychologi-
cal, and familial implications of genetic contributions to
disease. Therefore, it is important to have knowledge
about the health status of these individuals coming to
genetic counselling in order to be able to interpret, edu-
cate and counsel [33].
In the present study it was found that the socio-demo-
graphic variable influencing the health domains the
most was how the patient was referred to genetic coun-
selling. Being referred by a physician consistently
showed a negative relationship to all health status
domains. Other research has revealed that the patients
experience a lack of knowledge and understanding con-
cerning inherited arrhythmias among health-care provi-
ders [15,17,18,34], which previously have been described
Table 4 Multiple linear regression analysis assessing the relationship between socio-demographic variables, clinical
status and the SF-36 health status domains among the arrhythmia risk patients*
SF-36 Health status domains Socio-demographic variables
and clinical status
b Standard error p-value R2
Physical functioning Age -0.3 0.08 <0.001 0.518
Employment 12.7 2.64 <0.001
Heart disease in family -8.2 2.86 0.005
Referral -8.9 2.84 0.002
Role physical Age -0.5 0.19 0.013 0.390
Employment 27.8 6.55 <0.001
Genetic testing in family 7.1 4.19 0.095
Referral -22.6 7.94 0.005
Bodily pain Sex 13.3 4.40 0.003 0.326
Employment 13.4 4.89 0.008
Education status 6.8 3.15 0.032
Sudden death in the family 8.7 4.45 0.054
Referral -22.7 4.98 <0.001
General health Employment 17.5 3.77 <0.001 0.391
Education status 4.4 2.43 0.073
Heart disease in the family -8.0 4.05 0.052
Referral -14.8 4.10 0.001
Vitality Sex 10.0 4.44 0.027 0.302
Employment 11.8 4.95 0.019
Education status 11.0 3.19 0.001
Referral -18.2 5.05 0.001
Social functioning Employment 12.1 4.22 0.005 0.379
Education status 10.6 2.72 <0.001
Referral -20.3 4.30 <0.001
Role emotional Employment 33.3 7.07 <0.001 0.320
Referral -31.2 7.39 <0.001
Mental health Sex 8.4 3.52 0.019 0.316
Children -7.5 4.49 0.097
Education status 11.5 2.42 <0.001
Referral -20.9 3.47 0.001
Clinical status 7.2 5.84 0.040
*Model developed from backward stepwise selection of all socio-demographic and clinical predictors from the fully adjusted model fulfilling the inclusion criteria
with p = 0.05 and exclusion criteria with p > 0.1 reported with unstandardised coefficients (b), standard error, p-values (p) and Adjusted R Square (R2). Coding of
the independent variables: sex; female = 0, male = 1, children; no = 0, yes = 1, employment; no = 0, yes = 1, education status; primary school = 1, high school =
2, college/university = 3, heart disease in family; LQTS = 1, HCM = 2, sudden death in family; no = 0, yes = 1, genetic testing in family; no = 0, yes = 1, referral;
by family member = 0, by physician = 1, clinical status; family risk = 0, LQTS = 1, HCM = 2. Age was treated as continuous. The dependent variables: The SF-36
health status domains were treated as continuous (0-100).
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to have the potential of creating uncertainty, lead to
misinformation and wrong treatment advice [16]. Being
referred by a physician might influence the patient’s per-
ception and understanding of the content of information
that is received in this setting compared to when
patients are self-referred through a family member.
Although it might also be that the patients rate their
condition more seriously if the health care provider
refers them to genetic counselling, expecting it is more
serious then, or that the patients referred by the physi-
cian do have actual symptoms of disease. Regardless,
being referred to genetic counselling will provide the
possibility of getting the information necessary to be
able to adapt to and understand the situation, which
according to previous research [17] can be key predic-
tors to an improved general health status in inherited
arrhythmias.
Limitations
The design of this study shares the limitations that all
cross-sectional designs have regarding control, causality
and generalisability. Our sample size was relatively
small; however the data was collected at three different
hospitals in three different health regions of Norway to
reduce possible influence of community characteristics.
An important issue in discussing the findings in the
present study are whether the research sample is repre-
sentative of a greater population and what kind of biases
might influence the results. Ideally we would like to
generalize the finding in our study to all subjects under-
going genetic counselling for LQTS and HCM. The rate
of decliners in the study was fairly high (26.6%). The
Regional Committee for Medical and Health Research
Ethics did not permit publication of data related to
information for individuals who did not consent for
research. Therefore, it was not possible to compare
respondents to non-respondents. We cannot rule out
the possibility that the decliners are different than the
respondents. More health problems among non-respon-
ders [35], could be an alternative explanation for the
somewhat better health scores in the present study, than
what could have been expected.
The arrhythmia risk groups were different from each
other with the distribution of some of the socio-demo-
graphic variables, but even if this mostly was controlled
for in the analysis, there can be other variables that
influence also. In the genetic counselling setting it is
however interesting to analyse the groups together since
it is not so much the clinical manifestations that are
central to the research questions, but more the attempt
to elucidate a major unmeasured component of overall
health risk, the extent to which knowledge gained about
the potential harm associated with the risk of disease
affects the outcome of the subjective health status of the
patients coming to genetic counselling. We were able in
this study to explain considerable variance in the depen-
dent variables with the socio-demographic variables and
clinical status. However some variance in health status
is yet to be explained, such as the influence of psychoso-
cial variables.
Conclusions
In conclusion, living with genetic risk of arrhythmia and
possible sudden death is most likely related to health
status vulnerability. In general, persons at genetic risk of
arrhythmia perceive their current health; health outlook
and resistance to illness to be lower than the general
population, and for persons with HCM, physical health
and emotional problems can in addition limit and inter-
fere with work or daily activities. Lower health status
reported on general health suggests that the arrhythmia-
risk patients indeed is a special patient-group, a finding
adding to the knowledge that this patient group can
benefit particularly from genetic counselling. Prospective
studies might give more insights to the effect of genetic
counselling.
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